{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05904548",
            "orgStudyIdInfo": {
                "id": "VISABL-AFL"
            },
            "organization": {
                "fullName": "Imricor Medical Systems",
                "class": "INDUSTRY"
            },
            "briefTitle": "Atrial Flutter Ablation in the iCMR",
            "officialTitle": "Vision-MR Ablation Catheter 2.0 for Treatment of Type I Atrial Flutter",
            "acronym": "VISABL-AFL",
            "therapeuticArea": [
                "Other"
            ],
            "study": "atrial-flutter-ablation-in-the-icmr"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-06-20",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-04-13",
            "studyFirstSubmitQcDate": "2023-06-12",
            "studyFirstPostDateStruct": {
                "date": "2023-06-15",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-19",
            "lastUpdatePostDateStruct": {
                "date": "2024-06-21",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Imricor Medical Systems",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The VISABL-AFL clinical investigation is a prospective, single-arm, multi-center, interventional, Investigational Device Exemption (IDE) trial. The primary objectives of VISABL-AFL are to assess the safety and efficacy of radiofrequency (RF) ablation of type-I atrial flutter performed with the Vision-MR Ablation Catheter 2.0 in the iCMR environment."
        },
        "conditionsModule": {
            "conditions": [
                "Atrial Flutter Typical"
            ],
            "keywords": [
                "RF Ablation",
                "interventional Cardiac Magnetic Resonance (iCMR)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 91,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Vision-MR Atrial Flutter Ablation",
                    "type": "EXPERIMENTAL",
                    "description": "Type 1 Atrial Flutter ablation performed in the iCMR with the Vision-MR Ablation Catheter 2.0 and associated Advantage-MR EP recorder and stimulator system.",
                    "interventionNames": [
                        "Device: RF Ablation"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "RF Ablation",
                    "description": "RF ablation for type I atrial flutter under iCMR guidance",
                    "armGroupLabels": [
                        "Vision-MR Atrial Flutter Ablation"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Primary Efficacy Endpoint: Bi-directional block confirmation",
                    "description": "Confirmation of bidirectional conduction block of the CTI with the Vision-MR Ablation Catheter 2.0 and Osypka HAT 500 RF generator \\& irrigation pump.",
                    "timeFrame": "Time of procedure, following delivery of last ablation energy delivery point"
                },
                {
                    "measure": "Primary Safety Endpoint: Composite of serious cardiovascular adverse events",
                    "description": "A composite of the following serious adverse events as adjudicated by an independent clinical events committee:\n\n* Cardiac perforation/tamponade\n* Cerebrovascular accident (CVA)\n* Transient ischemic attack (TIA)\n* Complete heart block\n* Myocardial infarction\n* Pulmonary embolism\n* MR-related serious adverse events\n* Unanticipated device related serious adverse events\n* Death",
                    "timeFrame": "7-days post procedure"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Chronic Efficacy Endpoint: Freedom from type 1 atrial flutter at 90 days",
                    "description": "The percent of subjects free of documented type I atrial flutter recurrence",
                    "timeFrame": "3 months (90 days)"
                },
                {
                    "measure": "Chronic Safety Endpoint: all serious adverse event rate for duration of study",
                    "description": "Rate of Serious Adverse Events during the clinical investigation as adjudicated by an independent clinical events committee",
                    "timeFrame": "3 months (90 days)"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient indicated for type I atrial flutter ablations with at least 1 documented episode of type I atrial flutter within 6 months (180 days) of enrollment\n* Patient 18 years and older\n\nExclusion Criteria:\n\n* Contraindications for MRI procedures\n* Patients who cannot have anti-arrhythmic drugs (class I or class III) prescribed for the treatment of type I atrial flutter stopped on the day of the procedure\n* Previous CTI ablation procedures\n* Myocardial infarction within 60 days of enrollment\n* Current unstable angina\n* Cardiac surgery within 90 days of enrollment\n* Any cerebral ischemic event (including transient ischemic attacks) within 6 months (180 days) of enrollment\n* Thrombocytosis or thrombocytopenia\n* Contraindication to anticoagulation therapy\n* Currently documented intracardiac thrombus or myxoma\n* Implantation of permanent leads of an implantable device in or through the right atrium within 90 days of enrollment\n* Prosthetic valve through which the catheter must pass\n* Interatrial baffle or patch through which the catheter must pass\n* Moderate or severe tricuspid valve regurgitation or stenosis\n* Uncompensated congestive heart failure\n* Active systemic infection\n* Pregnancy or if subject plans to become pregnant during the trial\n* Uncontrolled hyperthyroidism\n* Any other significant uncontrolled or unstable medical condition\n* Enrollment in any concurrent study without Imricor written approval\n* Life expectancy of less than or equal to 2 years (730 days) per physician opinion",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Kate Lindborg, PhD",
                    "role": "CONTACT",
                    "phone": "9528188400",
                    "email": "kate.lindborg@imricor.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kate Lindborg, PhD",
                    "affiliation": "Imricor Medical Systems, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Johns Hopkins University",
                    "status": "RECRUITING",
                    "city": "Baltimore",
                    "state": "Maryland",
                    "zip": "21218",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Aravindan Kolandaivelu, MD",
                            "role": "CONTACT"
                        },
                        {
                            "name": "Aravindan Kolandaivelu, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.29038,
                        "lon": -76.61219
                    }
                },
                {
                    "facility": "l'institut Cardiologique Paris Sud (ICPS)",
                    "status": "RECRUITING",
                    "city": "Massy",
                    "zip": "91300",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Laurent Fiorina, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 48.72692,
                        "lon": 2.28301
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001282",
                    "term": "Atrial Flutter"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001145",
                    "term": "Arrhythmias, Cardiac"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M4587",
                    "name": "Atrial Flutter",
                    "asFound": "Atrial Flutter",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4453",
                    "name": "Arrhythmias, Cardiac",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M251802",
                    "name": "Imidacloprid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}